GlassScriptPhysician profile
Warren K Mciver
NPI 1174529671
$2,365.79
in general payments reported to CMS, 2019-2025
15 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $59.29 · 2021: $165 · 2022: $449 · 2023: $260 · 2024: $277 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $564.93 | 2019-2022 | |
| Medtronic, INC. | $270.64 | 2025 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $234.81 | 2021-2023 | Krystexxa |
| Stryker Corporation | $214.42 | 2019-2024 | Easyfuse |
| Wright Medical Technology, INC. | $158.51 | 2019-2020 | |
| Organogenesis INC. | $147.02 | 2024 | Novachor, Affinity, Nushield |
| Nevro Corp. | $145.25 | 2022 | |
| Smith+Nephew, INC. | $137.98 | 2022-2023 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $124.48 | 2019-2023 | Kimyrsa |
| Depuy Synthes Sales INC. | $99.99 | 2019 | |
| Kerecis Limited | $94.16 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Rikco International, LLC | $88.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $48.05 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $25.45 | 2022 | |
| Bioventus LLC | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Mciver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.